跳至主要内容
临床试验/NCT01030393
NCT01030393已完成4 期

Intra-uterine Injection of Human Chorionic Gonadotrophin Before Embryo Transfer in ICSI

The Egyptian IVF-ET Center1 个研究点 分布在 1 个国家目标入组 472 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
472
试验地点
1
主要终点
implantation and pregnancy rates

研究概览

简要总结

Chorionic gonadotrophins (hCG) play an important role in implantation. The aim of the study is to evaluate the effect of intrauterine injection of hCG before embryo transfer in IVF/ICSI on the implantation and pregnancy rates. The rational is that intrauterine hCG injection will attract regulatory T cells and improve implantation.

详细描述

Background :

Human chorionic gonadotrophin ( hCG) was found to secreted immediately after fertilization by the embryo. It plays an important role in implantation and in attracting regulatory T cells to the endometrium.

Rational :

Intrauterine injection of hCG before embryo transfer in IVF/ICSI may increase endometrial regulatory T cells ( Treg ) and improve the implantation and pregnancy rates.

Aim of the work :

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 39 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • male factor infertility
  • normal female hormonal profile
  • normal uterine cavity

排除标准

  • previous ICSI failure
  • endometriosis
  • azoospermia

研究组 & 干预措施

intrauterine hCG

Experimental

Experimental arm : intrauterine injection of 100 iu(group1)or 200 iu (group2) of hCG before embryo transfer.

Intrauterine injection of 500 iu hCG before embryo transfer

干预措施: human chorionic gonadotrophin (Drug)

结局指标

主要结局

implantation and pregnancy rates

时间窗: 5 weeks after embryo transfer

次要结局

  • miscarriage and delivery rates(9 months from embryo transfer)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ragaa Mansour

Director

The Egyptian IVF-ET Center

研究点 (1)

Loading locations...

相似试验